IDT Australia (ASX: IDT) share price surges 16% on vaccine government talks

IDT shares are well on the move this morning after a key update.

| More on:
A drawing of a rocket follows a chart up, indicating share price lift

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The IDT Australia Limited (ASX: IDT) share price has soared into the green during early trade on Monday.

IDT shares are on the move as the pharmaceuticals company gave a key update.

Let's investigate further.

What did IDT announce?

IDT provided some additional colour on a previous announcement made on 22 July regarding the company "potentially providing cGMP manufacturing services" for an mRNA vaccine candidate.

Recall that IDT had previously stated it could manufacture up to 100 million doses of an mRNA vaccine within 18 months.

On Monday, IDT confirmed that these discussions "recently extended" to include the Commonwealth and Victorian Governments, alongside Monash University. IDT stated the discussions "are progressing well".

Moreover, IDT advised that its sterile readiness agreement with the Department of Health to bring "IDT's sterile manufacturing facility into a state of readiness to produce a Covid-19 vaccine" was finalised.

This agreement "provides for an exclusivity period" with the Australian government under one of two outcomes (as per the release):

  • Executing a supply agreement for IDT to provide Covid-19 vaccine services to the department of heath, OR
  • Four months from competion of IDT's sterile readiness works.

In other words, IDT's efforts to ready the facility is on a "vaccine agnositc basis", meaning the company will have the site prepared, and only if and when the government calls upon them to produce a Covid-19 vaccine will IDT do so.

In addition, an important note for consideration is that the decision to manufacture the vaccine is at the Government's discretion.

As a result, investors are buying IDT shares in droves after the news, pushing the IDT Australia share price higher.

IDT shares are now exchanging hands at 70 cents apiece, a 27% surge into the money from the open.

IDT Australia share price snapshot

The IDT share price has posted a year to date return of 278%, extending the previous 12 month's gain of 312%.

These returns have outpaced the S&P/ASX 200 Index (ASX: XJO)'s climb of around 25% over the past year.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

3 children standing on podiums wearing Olympic medals
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rather woeful Wednesday session for the ASX today.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why 4DMedical, Megaport, Meteoric Resources, and Ramelius shares are racing higher today

These shares are having a good session on hump day. But why?

Read more »

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup
Share Gainers

Here are the top 10 ASX 200 shares today

It was a dour Tuesday for ASX investors.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Brightstar Resources, Immutep, Pilbara Minerals, and Race Oncology shares are roaring higher

These shares are having a strong session on Tuesday. But why?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield kind of Monday for investors.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today

These shares are starting the week in a positive fashion. But why?

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »